Efficacy and Safety of Linperlisib in Relapsed/Refractory Large Granular T Lymphocytic Leukemia
Clinical trial NCT06224257 · RECRUITING
Trial details
- NCT number
- NCT06224257
- Sponsor
- Institute of Hematology & Blood Diseases Hospital, China
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-12-03
- Primary completion
- 2025-10-31
- Enrollment
- 41
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.